Aquiline Capital Partners (Aquiline), a private investment firm with over $10bn in AUM, has made a majority investment in PharmaForce, a pharmacy solutions provider to hospitals and health clinics. Financial terms of the deal have not been disclosed.
The provider has delivered 340B administration software to over 280 clients since its inception in 2017 and recently launched a pharmacy benefits management offering.
In a press statement, PharmaForce said that, with Aquiline’s backing, it will “accelerate strategic M&A and continue to expand its product capabilities”.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Piper Sandler served as financial advisor to PharmaForce. Legal counsel was provided by Taft and Ropes & Gray to PharmaForce and Aquiline respectively.
Source: Private Equity Wire
Can’t stop reading? Read more
Citibank partners with SDX to tokenise $75bn private equity market with Q3 2025 launch
Citibank partners with SDX to tokenise $75bn private equity market with Q3 2025 launch Citibank...
General Atlantic takes minority stake in Liftoff at $4.3bn valuation as Blackstone retains control
General Atlantic takes minority stake in Liftoff at $4.3bn valuation as Blackstone retains control...
CVC Capital Partners weighs £6bn takeover of duty-free retailer Avolta
CVC Capital Partners weighs £6bn takeover of duty-free retailer Avolta CVC Capital Partners is...